GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Stryker Corporation (SYK) [hlAlert]

Rating:
Neutral SYK
down 40.79 %

Stryker Corporation (SYK) downgraded to Neutral by Cowen & Co

Posted on: Tuesday,  Jan 6, 2009  9:25 AM ET by Cowen & Co

Cowen & Co rated Neutral Stryker Corporation (NYSE: SYK) on 01/06/2009. Previously Cowen & Co rated Outperform Stryker Corporation (NYSE: SYK) on
01/18/2008., when the stock price was $65.86. Since then, Stryker Corporation has lost 40.80% as of 01/06/2009's recent price of $38.99.
If you would have followed the previous Cowen & Co's recommendation on SYK, you would have lost 40.79% of your investment in 354 days.

Stryker Corporation (Stryker) is a medical technology company with a range of products in orthopaedics and a presence in other medical specialties. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose and throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. The Company operates in two business segments: Orthopaedic Implants and MedSurg Equipment. The Orthopaedic Implants segment sells orthopaedic reconstructive (hip, knee and shoulder), trauma, craniomaxillofacial and spinal implant systems; bone cement; and the bone growth factor OP-1. The MedSurg Equipment segment sells surgical equipment; surgical navigation systems; endoscopic, communications and digital imaging systems; as well as patient handling and emergency medical equipment.

Cowen and Company’s culture is rooted in the traditions of the research boutiques that once dominated the investment research landscape. Our primary focus is on two products: 1. Proprietary information flow, and 2. Good investment ideas We achieve the first objective with a combination of extensive primary research work, organized survey activity, and access to industry experts (i.e., opinion leaders in medicine, technology, and consumer industries). We believe that the best investment idea is a “Correct Non-Consensus Conclusion,” and a considerable amount of our energy is devoted to this pursuit. We spend as little time as possible on traditional maintenance research products.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/6/2009 9:25 AM Hold
None
38.99
as of 12/31/2009
1 Week   
1 Month   
3 Months   
1 YTD down  -2.40 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/18/2008 8:25 AM Buy
None
65.86

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy